Bachrodt Amy (CIK 2050422) reported 25 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-04-02). Recent activity: Buy MAZE (2,500 shares), Sell MAZE (300 shares), Sell MAZE (2,200 shares), Buy MAZE (5,000 shares), Sell MAZE (1,300 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-02 | Maze Therapeutics, Inc. (MAZE) | SVP, Finance | Buy | 2,500 | $26,050 |
| 2026-04-02 | Maze Therapeutics, Inc. (MAZE) | SVP, Finance | Sell | 300 | $9,101 |
| 2026-04-02 | Maze Therapeutics, Inc. (MAZE) | SVP, Finance | Sell | 2,200 | $64,510 |
| 2026-03-03 | Maze Therapeutics, Inc. (MAZE) | SVP, Finance | Buy | 5,000 | $52,100 |
| 2026-03-03 | Maze Therapeutics, Inc. (MAZE) | SVP, Finance | Sell | 1,300 | $57,772 |
| 2026-03-03 | Maze Therapeutics, Inc. (MAZE) | SVP, Finance | Sell | 3,700 | $168,239 |
| 2026-02-04 | Maze Therapeutics, Inc. (MAZE) | SVP, Finance | Sell | 4,064 | $187,066 |
| 2026-02-04 | Maze Therapeutics, Inc. (MAZE) | SVP, Finance | Buy | 4,844 | $50,474 |
| 2026-02-04 | Maze Therapeutics, Inc. (MAZE) | SVP, Finance | Buy | 156 | $1,626 |
| 2026-02-04 | Maze Therapeutics, Inc. (MAZE) | SVP, Finance | Sell | 200 | $8,830 |
| 2026-02-04 | Maze Therapeutics, Inc. (MAZE) | SVP, Finance | Sell | 736 | $34,320 |
| 2026-01-26 | Maze Therapeutics, Inc. (MAZE) | SVP, Finance | Buy | 2,503 | $26,081 |
| 2026-01-26 | Maze Therapeutics, Inc. (MAZE) | SVP, Finance | Buy | 2,497 | $26,019 |
| 2026-01-26 | Maze Therapeutics, Inc. (MAZE) | SVP, Finance | Sell | 5,000 | $227,600 |
| 2026-01-06 | Maze Therapeutics, Inc. (MAZE) | SVP, Finance | Buy | 204 | $2,126 |
| 2026-01-06 | Maze Therapeutics, Inc. (MAZE) | SVP, Finance | Buy | 4,796 | $49,974 |
| 2026-01-06 | Maze Therapeutics, Inc. (MAZE) | SVP, Finance | Sell | 2,405 | $93,074 |
| 2026-01-06 | Maze Therapeutics, Inc. (MAZE) | SVP, Finance | Sell | 2,595 | $102,684 |
| 2025-12-31 | Maze Therapeutics, Inc. (MAZE) | SVP, Finance | Sell | 5,000 | $200,400 |
| 2025-12-31 | Maze Therapeutics, Inc. (MAZE) | SVP, Finance | Buy | 124 | $1,292 |
| 2025-12-31 | Maze Therapeutics, Inc. (MAZE) | SVP, Finance | Buy | 9,876 | $102,908 |
| 2025-12-31 | Maze Therapeutics, Inc. (MAZE) | SVP, Finance | Sell | 9,400 | $381,076 |
| 2025-12-31 | Maze Therapeutics, Inc. (MAZE) | SVP, Finance | Sell | 600 | $24,696 |
| 2025-12-31 | Maze Therapeutics, Inc. (MAZE) | SVP, Finance | Buy | 2,395 | $24,956 |
| 2025-12-31 | Maze Therapeutics, Inc. (MAZE) | SVP, Finance | Buy | 2,605 | $27,144 |
Source: SEC Form 4 filings · as of 2026-04-02